Aqemia is a rapidly growing pharmatech company focused on drug discovery using a unique combination of quantum-inspired physics and machine learning. The company has raised $60 million in Series A funding to enhance its therapeutic pipeline and has announced a $140 million collaboration with Sanofi. Aqemia seeks to build a multi-disciplinary team dedicated to accelerating drug discovery.
Aqemia
Aqemia is a next-generation pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to scale the drug discovery process, by leveraging a unique-in-the world technology combining quantum-inspired physics and machine learning.
Latest News
AQEMIA Announces a Major Multi-year Collaboration of $140 Million With Sanofi
Aqemia Raises €30M to Scale its Deep Physics and AI Enabled Drug Discovery Pipeline
WORK WITH US
At Aqemia you will work in a multi-disciplinary team of passionate drug hunters, AI engineers and developers who are committed to our mission of finding drugs at high pace, to cure diseases.